58 related articles for article (PubMed ID: 19942704)
1. Brain iron imaging markers in the presence of white matter hyperintensities.
Murray KD; Tivarus ME; Schifitto G; Uddin MN; Zhong J
Magn Reson Imaging; 2023 May; 98():115-123. PubMed ID: 36682396
[TBL] [Abstract][Full Text] [Related]
2. Diffusion imaging in Huntington's disease: comprehensive review.
Estevez-Fraga C; Scahill R; Rees G; Tabrizi SJ; Gregory S
J Neurol Neurosurg Psychiatry; 2020 Oct; 92(1):62-9. PubMed ID: 33033167
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease.
Siew JJ; Chen HM; Chen HY; Chen HL; Chen CM; Soong BW; Wu YR; Chang CP; Chan YC; Lin CH; Liu FT; Chern Y
Nat Commun; 2019 Aug; 10(1):3473. PubMed ID: 31375685
[TBL] [Abstract][Full Text] [Related]
4. Basal ganglia-cortical structural connectivity in Huntington's disease.
Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
[TBL] [Abstract][Full Text] [Related]
5. Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker.
Ferraro S; Nanetti L; Piacentini S; Mandelli ML; Bertolino N; Ghielmetti F; Epifani F; Nigri A; Taroni F; Bruzzone MG; Di Donato S; Savoiardo M; Mariotti C; Grisoli M
Neurology; 2014 Jul; 83(1):65-72. PubMed ID: 24898924
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study.
Hobbs NZ; Cole JH; Farmer RE; Rees EM; Crawford HE; Malone IB; Roos RA; Sprengelmeyer R; Durr A; Landwehrmeyer B; Scahill RI; Tabrizi SJ; Frost C
Neuroimage Clin; 2012; 2():204-11. PubMed ID: 24179770
[TBL] [Abstract][Full Text] [Related]
7. Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Domínguez D JF; Egan GF; Gray MA; Poudel GR; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
PLoS One; 2013; 8(9):e74131. PubMed ID: 24066104
[TBL] [Abstract][Full Text] [Related]
8. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers.
Kelp A; Koeppen AH; Petrasch-Parwez E; Calaminus C; Bauer C; Portal E; Yu-Taeger L; Pichler B; Bauer P; Riess O; Nguyen HP
J Neurosci; 2013 May; 33(21):9068-81. PubMed ID: 23699518
[TBL] [Abstract][Full Text] [Related]
9. Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats.
Antonsen BT; Jiang Y; Veraart J; Qu H; Nguyen HP; Sijbers J; von Hörsten S; Johnson GA; Leergaard TB
Brain Struct Funct; 2013 May; 218(3):767-78. PubMed ID: 22618438
[TBL] [Abstract][Full Text] [Related]
10. Magnetization transfer MR imaging demonstrates degeneration of the subcortical and cortical gray matter in Huntington disease.
Ginestroni A; Battaglini M; Diciotti S; Della Nave R; Mazzoni LN; Tessa C; Giannelli M; Piacentini S; De Stefano N; Mascalchi M
AJNR Am J Neuroradiol; 2010 Nov; 31(10):1807-12. PubMed ID: 20813872
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease.
Sritharan A; Egan GF; Johnston L; Horne M; Bradshaw JL; Bohanna I; Asadi H; Cunnington R; Churchyard AJ; Chua P; Farrow M; Georgiou-Karistianis N
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):257-62. PubMed ID: 19237387
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.
Ryan NS; Keihaninejad S; Shakespeare TJ; Lehmann M; Crutch SJ; Malone IB; Thornton JS; Mancini L; Hyare H; Yousry T; Ridgway GR; Zhang H; Modat M; Alexander DC; Rossor MN; Ourselin S; Fox NC
Brain; 2013 May; 136(Pt 5):1399-414. PubMed ID: 23539189
[TBL] [Abstract][Full Text] [Related]
13. Diffusion imaging studies of Huntington's disease: A meta-analysis.
Liu W; Yang J; Burgunder J; Cheng B; Shang H
Parkinsonism Relat Disord; 2016 Nov; 32():94-101. PubMed ID: 27624391
[TBL] [Abstract][Full Text] [Related]
14. [Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers].
Wolf RC; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer GB
Nervenarzt; 2008 Apr; 79(4):408-20. PubMed ID: 18074113
[TBL] [Abstract][Full Text] [Related]
15. Decreased diffusivity in the caudate nucleus of presymptomatic huntington disease gene carriers: which explanation?
Mandelli ML; Savoiardo M; Minati L; Mariotti C; Aquino D; Erbetta A; Genitrini S; Di Donato S; Bruzzone MG; Grisoli M
AJNR Am J Neuroradiol; 2010 Apr; 31(4):706-10. PubMed ID: 19942704
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.
Vandenberghe W; Demaerel P; Dom R; Maes F
J Neurol; 2009 Jan; 256(1):109-14. PubMed ID: 19267169
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
